Статья

Genomic history of the seventh pandemic of cholera in Africa

F. Weill, D. Domman, E. Njamkepo, C. Tarr, J. Rauzier, N. Fawal, K. Keddy, H. Salje, S. Moore, A. Mukhopadhyay, R. Bercion, F. Luquero, A. Ngandjio, M. Dosso, E. Monakhova, B. Garin, C. Bouchier, C. Pazzani, A. Mutreja, R. Grunow, F. Sidikou, L. Bonte, S. Breurec, M. Damian, B. Njanpop-Lafourcade, G. Sapriel, A. Page, M. Hamze, M. Henkens, G. Chowdhury, M. Mengel, J. Koeck, J. Fournier, G. Dougan, P. Grimont, J. Parkhill, K. Holt, R. Piarroux, T. Ramamurthy, M. Quilici, N. Thomson,
2021

The seventh cholera pandemic has heavily affected Africa, although the origin and continental spread of the disease remain undefined. We used genomic data from 1070 Vibrio cholerae O1 isolates, across 45 African countries and over a 49-year period, to show that past epidemics were attributable to a single expanded lineage. This lineage was introduced at least 11 times since 1970, into two main regions, West Africa and East/Southern Africa, causing epidemics that lasted up to 28 years. The last five introductions into Africa, all from Asia, involved multidrug-resistant sublineages that replaced antibiotic-susceptible sublineages after 2000. This phylogenetic framework describes the periodicity of lineage introduction and the stable routes of cholera spread, which should inform the rational design of control measures for cholera in Africa. © 2017, American Association for the Advancement of Science. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • F. Weill
    Institut Pasteur, Unité des Bactéries Pathogènes Entériques, Paris, 75015, France
  • D. Domman
    Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, United Kingdom
  • E. Njamkepo
    Centers for Disease Control and Prevention, Escherichia and Shigella Reference Unit, Atlanta, GA 30333, United States
  • C. Tarr
    Centre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg, 2131, South Africa
  • J. Rauzier
    Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa
  • N. Fawal
    Institut Pasteur, Mathematical Modelling of Infectious Diseases, Paris, 75015, France
  • K. Keddy
    Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States
  • H. Salje
    Laboratoire de Parasitologie-Mycologie, CHU Timone, Université de la Méditerranée, Marseille, 13385, France
  • S. Moore
    National Institute of Cholera and Enteric Diseases (NICED), Kolkata, West Bengal 700010, India
  • A. Mukhopadhyay
    Institut Pasteur de Bangui, BP 923, Bangui, Central African Republic
  • R. Bercion
    Institut Pasteur de Dakar, BP 220, Dakar, Senegal
  • F. Luquero
    Epicentre, Paris, 75011, France
  • A. Ngandjio
    Centre Pasteur du Cameroun, BP 1274, Yaoundé, Cameroon
  • M. Dosso
    Bacteriology and Virology Department, Institut Pasteur, Abidjan, Cote d'Ivoire
  • E. Monakhova
    Rostov-on-Don Research Institute for Plague Control, Rostov-on-Don, 344022, Russian Federation
  • B. Garin
    Institut Pasteur, Plate-forme Génomique (PF1), Paris, 75015, France
  • C. Bouchier
    University of Bari A. Moro, Department of Biology, Bari, 70126, Italy
  • C. Pazzani
    Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 0SP, United Kingdom
  • A. Mutreja
    Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana 121001, India
  • R. Grunow
    Robert Koch Institute, Berlin, 13353, Germany
  • F. Sidikou
    Centre de Recherche Medicale et Sanitaire (CERMES), BP 10887, Niamey, Niger
  • L. Bonte
    Médecins Sans Frontières (MSF), Paris, 75011, France
  • S. Breurec
    Cantacuzino National Institute of Research-Development for Microbiology and Immunology, Bucharest, Romania
  • M. Damian
    Agence de Médecine Préventive (AMP), Paris, 75015, France
  • B. Njanpop-Lafourcade
    Université de Versailles Saint-Quentin-en-Yvelines, UFR des sciences de la santé Simone Veil, Montigny-le-Bretonneux, 78180, France
  • G. Sapriel
    Atelier de Bioinformatique, ISYEB, UMR 7205, Paris, 75005, France
  • A. Page
    Laboratoire Microbiologie Santé et Environnement (LMSE), EDST-FSP, Université Libanaise, Tripoli, Lebanon
  • M. Hamze
    Médecins Sans Frontières, Brussels, B 1050, Belgium
  • M. Henkens
    Centre Hospitalier des Armées Bouffard, Djibouti, Djibouti
  • G. Chowdhury
    Institut Pasteur, Unité du Choléra et des Vibrions, Paris, 75015, France
  • M. Mengel
    Institut Pasteur, Unité Biodiversité des Bactéries Pathogènes Emergentes, Paris, 75015, France
  • J. Koeck
    Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia
  • J. Fournier
    London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom
  • G. Dougan
    University Hospital of Pointe-à-Pitre/Abymes, University of Antilles, Pointe-à-Pitre, France
  • P. Grimont
    Hôpital d’Instruction des Armées Robert Picqué, Villenave d’Ornon, France
  • J. Parkhill
  • K. Holt
  • R. Piarroux
  • T. Ramamurthy
  • M. Quilici
  • N. Thomson
Название журнала
  • Science
Том
  • 358
Выпуск
  • 6364
Страницы
  • 785-789
Ключевые слова
  • antibiotics; cholera; drug resistance; epidemic; genomics; periodicity; phylogenetics; Africa; antibiotic sensitivity; Article; bacterial genetics; bacterial genome; bacterium isolate; cholera; human; nonhuman; pandemic; periodicity; phylogeny; priority journal; single nucleotide polymorphism; Vibrio cholerae O1; Asia; cholera; classification; genetics; genomics; isolation and purification; microbiology; Asia; Southern Africa; West Africa; Vibrio cholerae; Africa, Eastern; Africa, Southern; Africa, Western; Asia; Cholera; Genome, Bacterial; Genomics; Humans; Pandemics; Phylogeny; Vibrio cholerae O1
Издатель
  • American Association for the Advancement of Science
Тип документа
  • journal article
Источник
  • scopus